ERN1 and Alzheimer disease: While MKC-3946, a small-molecule IRE1α endoribonuclease domain inhibitor, can ameliorate ER stress and suppress ROS production by inhibiting the XBP1s expression via blocking its mRNA splicing in vitro and in vivo, that results in diminished VSMC apoptosis and retarded AD formation and progression.